Clinical Trials
Viz.ai to Expedite Patient Enrollment in NIH-funded PE-TRACT Clinical Trial
Viz.ai has announced it will use its Viz Recruit platform to optimise patient enrolment for the National Institutes of Health (NIH)-funded Pulmonary embolism—thrombus removal with catheter-directed thrombolysis (PE-TRACT) clinical trial.
The company claims that PE-TRACT will be the most rigorous...
Clinical Trials
Greenphires ConneX Global Travel Solution Expands In-Country Support, Resulting in Significant Growth as Clinical Trial Travel Returns Post-Pandemic
Greenphire, the global leader in financial lifecycle management for clinical trials, announced significant expansion and growth of ConneX, the industry's most comprehensive clinical trial travel solution designed to help meet the retention goals of global studies.
ConneX has expanded upon...
Clinical Trials
First CAR-T Cell For Muscle Inflammation Cure Rolled Out
One of the university hospitals in Germany was the first in the world to effectively treat a patient with a severe case of muscular inflammation (myositis) using chimeric antigen receptor CAR-T cells.
The danger of acquiring an extremely severe form...
Clinical Trials
Institutional Review Boards Are In Need For More Monitoring
The Government Accountability Office has issued an analysis suggesting that the FDA should increase its oversight of institutional review boards (IRBs) to better protect the safety of participants across clinical trials. The analysis has gone on to find that...
Clinical Trials
Spinal Cord Stimulation May Be A Boon For Stroke Patients
A small clinical trial has suggested that spinal cord stimulation may help stroke patients regain movement in their limbs and hands. In an article published in Nature Medicine, researchers detailed the experience of the first two people treated in...
Clinical Trials
HIV Simplified Treatment Options Effective In A Major Trial
As per the results of international research, which has the distinction of being the world’s first study into second-line human immunodeficiency virus- HIV therapy, 2 newer and simplified options in treatment are as effective as the standards of care...
Clinical Trials
Kidney Cancer Recurrence Can Be Gauged By DNA Mutations
One of the international studies on kidney cancer recurrence has found that physicians can forecast the likelihood of a disease returning by way of examining DNA mutations in the patients' tumours.
The study was undertaken by a team of 44...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read